莎普爱思：二氟尼柳片通过仿制药质量和疗效一致性评价

Core Viewpoint - The company has received approval from the National Medical Products Administration for the drug Diflunisal Tablets, indicating a significant regulatory milestone for the company in the pharmaceutical sector [1] Group 1: Drug Approval Details - The drug name is Diflunisal Tablets, available in dosages of 0.25g and 0.5g [1] - The registration category is classified as a chemical drug, with the company being both the marketing authorization holder and the manufacturer [1] - The approval conclusion states that it is considered to have passed the consistency evaluation of quality and efficacy for generic drugs [1]